Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells

Xiaoming Jiang(University of Macau), Jin‐Jian Lu(University of Macau)
Acta Pharmacologica Sinica
September 7, 2017
Cited by 76


Related Papers